Show simple item record

dc.contributor.advisorChris Caplice and Donald Rosenfield.en_US
dc.contributor.authorSekar, Swaminathanen_US
dc.contributor.otherLeaders for Manufacturing Program.en_US
dc.date.accessioned2011-05-23T18:14:16Z
dc.date.available2011-05-23T18:14:16Z
dc.date.copyright2010en_US
dc.date.issued2010en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/63079
dc.descriptionThesis (S.M.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science; and, (M.B.A.)--Massachusetts Institute of Technology, Sloan School of Management; in conjunction with the Leaders for Manufacturing Program at MIT, 2010.en_US
dc.descriptionCataloged from PDF version of thesis.en_US
dc.descriptionIncludes bibliographical references (p. 62-63).en_US
dc.description.abstractThis paper addresses two basic questions about the outbound distribution operations with a case study example of a large biopharmaceutical company. First, the research work focuses on developing an efficient, scalable truck distribution system to help reduce transportation cost, while maintaining the service level and capacity constraints. In doing so, the paper examines the Vehicle Routing Problem (VRP), a NP-hard combinatorial optimization in the context of biopharmaceutical customer demand fulfillment process. The thesis presents a model developed to perform distribution center decisions, with Amgen North America market as case study. The second question addressed in this paper is a study on the number of distribution centers and possible locations. In a market with a certain geographic distribution of customers, and a desired number of distribution centers to operate, the analysis compares the different potential locations from standpoint of transportation cost, inventory level and site loading. The model is well suited for a company expanding into a new market to make decision on location of distribution centers to cater to a certain spread of customers in that region. The paper presents analyses for a real case study to provide contextual example, as well as more broad recommendations in the field. Both models are scalable to markets outside North America for similar companies.en_US
dc.description.statementofresponsibilityby Swaminathan Sekar.en_US
dc.format.extent63 p.en_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectElectrical Engineering and Computer Science.en_US
dc.subjectSloan School of Management.en_US
dc.subjectLeaders for Manufacturing Program.en_US
dc.titleDeveloping a framework for global distribution in the biopharmaceutical industryen_US
dc.typeThesisen_US
dc.description.degreeM.B.A.en_US
dc.description.degreeS.M.en_US
dc.contributor.departmentLeaders for Manufacturing Program at MITen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
dc.contributor.departmentSloan School of Management
dc.identifier.oclc725921852en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record